Citation Impact
Citing Papers
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
2012
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Pathogenesis of type 2 diabetes mellitus
2004
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
2007 Standout
Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
2007
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals
2006
Non-Transgenic Mouse Models of Kidney Disease
2016 Standout
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
2013
The gut–renal axis: do incretin-based agents confer renoprotection in diabetes?
2013
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009
2010
Extracting medication information from clinical text
2010
Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice
2006
Cancer-associated cachexia
2018 Standout
Skeletal muscle triglyceride: Marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus?
2002
eNOS Knockout Mice with Advanced Diabetic Nephropathy Have Less Benefit from Renin-Angiotensin Blockade than from Aldosterone Receptor Antagonists
2009
Equine Metabolic Syndrome
2010 Standout
Data from clinical notes: a perspective on the tension between structure and flexible documentation
2011
Insulin signalling and the regulation of glucose and lipid metabolism
2001 StandoutNature
Development and evaluation of a de-identification procedure for a case register sourced from mental health electronic records
2013 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin Resistance
2008 Standout
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
2011 Standout
Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle
2000
Molecular mechanisms of necroptosis: an ordered cellular explosion
2010 Standout
Electronic Medical Records (EMRs), Epidemiology, and Epistemology: Reflections on EMRs and Future Pediatric Clinical Research
2011
Type 2 diabetes mellitus
2015 Standout
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients
2004
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
2014
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Pathogenesis of Insulin Resistance in Skeletal Muscle
2010
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Coordinated patterns of gene expression for substrate and energy metabolism in skeletal muscle of diabetic mice
2002
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Exercise and Physical Activity for Older Adults
2009 Standout
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
2014
Reciprocal Relationships Between Insulin Resistance and Endothelial Dysfunction
2006 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
2002 Standout
Adiponectin and Adiponectin Receptors
2005 Standout
The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes
2004
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
2004 Standout
Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
2002
The Challenge of Measuring Quality of Care From the Electronic Health Record
2009
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Diabetic Kidney Disease
2017 Standout
Hexokinase Isozyme Distribution in Human Skeletal Muscle
2001
Skeletal muscle insulin resistance: role of mitochondria and other ROS sources
2017
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Impact of Aerobic Exercise Training on Age-Related Changes in Insulin Sensitivity and Muscle Oxidative Capacity
2003
Mechanisms of Diabetic Complications
2013 Standout
Extracting Information from Textual Documents in the Electronic Health Record: A Review of Recent Research
2008
Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction
2014
The Metabolic Syndrome
2008 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
2001
Nonalcoholic Fatty Liver Disease
2015 Standout
Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial
2013
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
2000
Works of M. Pendergrass being referenced
Impaired Vascular Reactivity in African-American Patients with Type 2 Diabetes Mellitus and Microalbuminuria or Proteinuria Despite Angiotensin-Converting Enzyme Inhibitor Therapy
2006
Using Regular Expressions to Abstract Blood Pressure and Treatment Intensification Information from the Text of Physician Notes
2006
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
2010
Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis
2012
Comparison of Information Content of Structured and Narrative Text Data Sources on the Example of Medication Intensification
2009
Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
1998